BidaskClub upgraded shares of Galapagos (NASDAQ:GLPG) from a sell rating to a hold rating in a research note released on Tuesday morning.

A number of other analysts have also commented on the stock. Zacks Investment Research lowered shares of Galapagos from a hold rating to a sell rating in a research note on Wednesday, December 27th. Stifel Nicolaus reiterated a buy rating and issued a $120.00 price target on shares of Galapagos in a research note on Sunday, October 29th. BTIG Research reiterated a buy rating and issued a $118.00 price target on shares of Galapagos in a research note on Monday, November 20th. Morgan Stanley reiterated an overweight rating and issued a $123.00 price target (up from $92.00) on shares of Galapagos in a research note on Friday, October 6th. Finally, ValuEngine lowered shares of Galapagos from a hold rating to a sell rating in a research note on Friday, December 1st. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the company. The company currently has a consensus rating of Hold and an average price target of $111.00.

Shares of Galapagos (GLPG) traded up $2.94 during mid-day trading on Tuesday, hitting $112.44. 98,101 shares of the stock were exchanged, compared to its average volume of 61,241. Galapagos has a 52-week low of $63.69 and a 52-week high of $113.04. The company has a market capitalization of $5,577.58, a price-to-earnings ratio of -122.22 and a beta of 1.58.

Galapagos (NASDAQ:GLPG) last announced its quarterly earnings results on Tuesday, October 24th. The biotechnology company reported ($0.85) EPS for the quarter, missing analysts’ consensus estimates of ($0.78) by ($0.07). Galapagos had a negative return on equity of 4.64% and a negative net margin of 22.26%. analysts forecast that Galapagos will post -2.56 earnings per share for the current fiscal year.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Advisors Preferred LLC bought a new stake in Galapagos during the third quarter valued at approximately $105,000. Envestnet Asset Management Inc. grew its position in Galapagos by 156.6% during the third quarter. Envestnet Asset Management Inc. now owns 1,742 shares of the biotechnology company’s stock valued at $177,000 after buying an additional 1,063 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in Galapagos during the third quarter valued at approximately $218,000. New York State Common Retirement Fund bought a new stake in Galapagos during the second quarter valued at approximately $166,000. Finally, Comerica Bank bought a new stake in Galapagos during the second quarter valued at approximately $221,000. Institutional investors own 19.68% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This article was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.thecerbatgem.com/2018/01/20/galapagos-glpg-upgraded-by-bidaskclub-to-hold.html.

Galapagos Company Profile

Galapagos NV is a Belgium-based biotechnology company. The Company’s activities are divided into two operating divisions: Research and Development (R & D) and Services. The R & D division is engaged in the discovery and development of small molecules. The Services division, offers target-to-drug discovery products and services to pharmaceutical and biotechnology companies and to patient foundations, encompassing target discovery and validation, screening and drug discovery through to delivery of pre-clinical candidates.

Analyst Recommendations for Galapagos (NASDAQ:GLPG)

Receive News & Ratings for Galapagos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galapagos and related companies with MarketBeat.com's FREE daily email newsletter.